1-3 of 3
Luc-Matthieu Fornecker, MD
Close
Sort by
Journal Articles

Frontline Therapy with the Ribvd Regimen Elicits High Clinical and Molecular Response Rates and Long PFS in Elderly Patients Mantle Cell Lymphoma (MCL); Final Results of a Prospective Phase II Trial By the Lysa Group

Remy Gressin, MD, Mary Callanan, MD PhD, Nicolas Daguindau, MD, Adrian Tempescul, MD, Sylvain Carras, Marie Pierre Moles, MD, Guillaume Cartron, MD, Roch Houot, MD PhD, Caroline Dartigeas, MD, Jean Michel Pignon, MD, Selim Corm, MD PhD, Anne Banos, MD, Christiane Mounier, MD, Jehan Dupuis, MD, Margareth Macro, MD, Joel Fleury, MD, Fabrice Jardin, MD PhD, Lionel Karlin, Pierre Feugier, MD PhD, Luc Matthieu Fornecker, MD, Cecile Chabrot, Veronique Dorvaux, MD, Krimo Bouabdallah, MD, Sandy Amorin, MD, Reda Garidi, MD, Laurent Voillat, MD, Bertrand Joly, MD, Katell Le Dû, Nadine Morineau, Hacene Zerazhi, MD, Jean Fontan, Yazid Arkam, MD, Magda Alexis, MD, Vincent Delwail, MD, Jean Pierre Vilque, MD, Loic Ysebaert, MDPhD, Steven Le Gouill, MD PhD, Ghandi Damaj, MD
Journal: Blood
Blood (2014) 124 (21): 148.
https://doi.org/10.1182/blood.V124.21.148.148
Published: 2014
Journal Articles

Effect of Immune Modulation for Peripheral T-Cell Lymphoma in Response to Relapse after Allogeneic Hematopoietic Stem Cell Transplant: A Study of 63 Patients By the French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC).

Anne-Claire Mamez, MD, Vincent Levy, MD, Patrice Chevallier, MD PhD, Didier Blaise, MD, Stephane Vigouroux, MD, Alienor Xhaard, MD, Laure Vincent, MD, Nathalie Contentin, MD, Yves Beguin, MD PhD, Norbert Ifrah, Jean-Yves Cahn, Felipe Suarez, MD PhD, Ibrahim Yakoub-Agha, MD PhD, Pascal Turlure, MD, Eric Deconinck, Thierry Lamy, MD PhD, Anne Huynh, MD, Sébastien Maury, MD, Luc Matthieu Fornecker, MD, Jacques-Olivier Bay, MD PhD, Gaelle Guillerm, MD, Natacha Maillard, MD, Mohamad Mohty, MD PhD, Stephanie Nguyen, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3963.
https://doi.org/10.1182/blood.V124.21.3963.3963
Published: 2014
Journal Articles

Salvage Therapies in Patients with High-Risk Relapse After Fludarabine, Cyclophosphamide, Rituximab (FCR) for Chronic Lymphocytic Leukemia: The French CLL Intergroup Experience

Luc-Matthieu Fornecker, MD, Therese Aurran-Schleinitz, Anne-Sophie Michallet, MD, PhD, Bruno Cazin, MD, Jehan Dupuis, MD, Romain Guieze, MD, Marie-Sarah Dilhuydy, MD, Jean-Marc Zini, MD, PhD, Cécile Tomowiak, MD, Stéphane Leprêtre, MD, Florence Cymbalista, MD, PhD, Annie Brion, MD, Pierre Feugier, MD, PhD, Veronique Leblond, Loic Ysebaert, MD PhD
Journal: Blood
Blood (2012) 120 (21): 1796.
https://doi.org/10.1182/blood.V120.21.1796.1796
Published: 2012